Immunogenicity of inactivated rotavirus in rhesus monkey, and assessment of immunologic mechanisms

References

• Crawford SE, Ramani S, Tate JE, Parashar UD, Svensson L, Hagbom M, Franco MA, Greenberg HB, O’Ryan M, Kang G, et al. Rotavirus infection. Nat Rev Dis Primers. 2017;3(1):17083. doi:10.1038/nrdp.2017.83.
   PubMed Web of Science ®Google Scholar
• Chissaque A, Bauhofer AFL, Cossa-Moiane I, Sitoe E, Munlela B, Joao ED, Langa JS, Chilaúle JJ, Boene SS, Cassocera M, et al. Rotavirus a infection in pre- and post-vaccine period: risk factors, genotypes distribution by vaccination status and age of children in Nampula Province, Northern Mozambique (2015–2019). PLoS One. 2021;16(8):e0255720. doi:10.1371/journal.pone.0255720.
   PubMed Web of Science ®Google Scholar
• Troeger C, Khalil IA, Rao PC, Cao S, Blacker BF, Ahmed T, Armah G, Bines JE, Brewer TG, Colombara DV, et al. Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years. JAMA Pediatr. 2018;172(10):958–13. doi:10.1001/jamapediatrics.2018.1960.
   PubMed Web of Science ®Google Scholar
• Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(2):136–41. doi:10.1016/S1473-3099(11)70253-5.
   PubMed Web of Science ®Google Scholar
• Tate JE, Burton AH, Boschi-Pinto C, Parashar UD. Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000-2013. Clin Infect Dis. 2016;62(suppl 2):S96–105. doi:10.1093/cid/civ1013.
   PubMed Web of Science ®Google Scholar
• Li J, Wang H, Li D, Zhang Q, Liu N. Infection status and circulating strains of rotaviruses in Chinese children younger than 5-years old from 2011 to 2018: systematic review and meta-analysis. Hum Vaccin Immunother. 2021;17:1811–17. doi:10.1080/21645515.2020.1849519.
   PubMed Web of Science ®Google Scholar
• Organization. WH. Rotavirus vaccines WHO position paper – July 2021. Wkly Epidemiol Record. 2021;96:20.
   Google Scholar
• Clark A, Black R, Tate J, Roose A, Kotloff K, Lam D, Blackwelder W, Parashar U, Lanata C, Kang G, et al. Estimating global, regional and national rotavirus deaths in children aged <5 years: current approaches, new analyses and proposed improvements. PLoS One. 2017;12(9):e0183392. doi:10.1371/journal.pone.0183392.
   PubMed Web of Science ®Google Scholar
• Collaborators GBDCoD, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, Abd-Allah F, Abdela J, Abdelalim A, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1736–88. doi:10.1016/S0140-6736(18)32203-7.
   PubMed Web of Science ®Google Scholar
• Burke RM, Tate JE, Kirkwood CD, Steele AD, Parashar UD. Current and new rotavirus vaccines. Curr Opin Infect Dis. 2019;32(5):435–44. doi:10.1097/QCO.0000000000000572.
   PubMed Web of Science ®Google Scholar
• Abou-Nader A, Sauer M, Steele AD, Tate JE, Atherly D, Parashar UD, Santosham M, Nelson EAS. Global rotavirus vaccine introductions and coverage: 2006–2016. Hum Vaccin Immunother. 2018;14(9):1–40. doi:10.1080/21645515.2018.1470725.
   PubMed Web of Science ®Google Scholar
• Soares-Weiser K, Bergman H, Henschke N, Pitan F, Cunliffe N. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev. 2019;2019. doi:10.1002/14651858.CD008521.pub5.
   PubMedGoogle Scholar
• Bergman H, Henschke N, Hungerford D, Pitan F, Ndwandwe D, Cunliffe N, Soares-Weiser K. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev. 2021;2021(11):CD008521. doi:10.1002/14651858.CD008521.pub6.
   Google Scholar
• Otero CE, Langel SN, Blasi M, Permar SR. Maternal antibody interference contributes to reduced rotavirus vaccine efficacy in developing countries. PLoS Pathog. 2020;16(11):e1009010. doi:10.1371/journal.ppat.1009010.
   PubMed Web of Science ®Google Scholar
• Velasquez DE, Parashar U, Jiang B. Decreased performance of live attenuated, oral rotavirus vaccines in low-income settings: causes and contributing factors. Expert Rev Vaccines. 2018;17:1–17. doi:10.1080/14760584.2018.1418665.
   Web of Science ®Google Scholar
• Mwila K, Chilengi R, Simuyandi M, Permar SR, Becker-Dreps S. Contribution of maternal immunity to decreased rotavirus vaccine performance in low- and middle-income countries. Clin Vaccine Immunol. 2017;24(1). doi:10.1128/CVI.00405-16.
   PubMedGoogle Scholar
• Desselberger U. Differences of rotavirus vaccine effectiveness by country: likely causes and contributing factors. Pathogens. 2017;6(4):6. doi:10.3390/pathogens6040065.
   PubMed Web of Science ®Google Scholar
• Rogawski ET, Platts-Mills JA, Colgate ER, Haque R, Zaman K, Petri WA, Kirkpatrick BD. Quantifying the impact of natural immunity on rotavirus vaccine efficacy estimates: a clinical trial in Dhaka, Bangladesh (PROVIDE) and a simulation study. J Infect Dis. 2018;217(6):861–68. doi:10.1093/infdis/jix668.
   PubMed Web of Science ®Google Scholar
• Parker EP, Ramani S, Lopman BA, Church JA, Iturriza-Gomara M, Prendergast AJ, Grassly NC. Causes of impaired oral vaccine efficacy in developing countries. Future Microbiol. 2018;13(1):97–118. doi:10.2217/fmb-2017-0128.
   PubMed Web of Science ®Google Scholar
• Resch TK, Wang Y, Moon SS, Joyce J, Li S, Prausnitz M, Jiang B. Inactivated rotavirus vaccine by parenteral administration induces mucosal immunity in mice. Sci Rep. 2018;8(1):561. doi:10.1038/s41598-017-18973-9.
   PubMedGoogle Scholar
• Wang Y, Zade J, Moon SS, Weldon W, Pisal SS, Glass RI, Dhere RM, Jiang B. Lack of immune interference between inactivated polio vaccine and inactivated rotavirus vaccine co-administered by intramuscular injection in two animal species. Vaccine. 2019;37(5):698–704. doi:10.1016/j.vaccine.2018.12.043.
   PubMed Web of Science ®Google Scholar
• Yin N, Wu J, Kuang X, Lin X, Zhou Y, Yi S, Hu X, Chen R, Liu Y, Ye J, et al. Vaccination of pregnant rhesus monkeys with inactivated rotavirus as a model for achieving protection from rotavirus SA11 infection in the offspring. Hum Vaccin Immunother. 2021;17(12):5656–65. doi:10.1080/21645515.2021.2011548.
   PubMed Web of Science ®Google Scholar
• Lakatos K, McAdams D, White JA, Chen D. Formulation and preclinical studies with a trivalent rotavirus P2-VP8 subunit vaccine. Hum Vaccin Immunother. 2020;16:1957–68. doi:10.1080/21645515.2019.1710412.
   PubMed Web of Science ®Google Scholar
• Groome MJ, Koen A, Fix A, Page N, Jose L, Madhi SA, McNeal M, Dally L, Cho I, Power M, et al. Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2017;17(8):843–53. doi:10.1016/S1473-3099(17)30242-6.
   PubMed Web of Science ®Google Scholar
• Groome MJ, Fairlie L, Morrison J, Fix A, Koen A, Masenya M, Jose L, Madhi SA, Page N, McNeal M, et al. Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2020;20(7):851–63. doi:10.1016/S1473-3099(20)30001-3.
   PubMed Web of Science ®Google Scholar
• Wang Y, Azevedo M, Saif LJ, Gentsch JR, Glass RI, Jiang B. Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets. Vaccine. 2010;28(33):5432–36. doi:10.1016/j.vaccine.2010.06.006.
   PubMed Web of Science ®Google Scholar
• Velasquez DE, Wang Y, Jiang B. Inactivated human rotavirus vaccine induces heterotypic antibody response: correction and development of IgG avidity assay. Hum Vaccin Immunother. 2015;11(2):531–33. doi:10.4161/21645515.2014.988553.
   PubMed Web of Science ®Google Scholar
• Jiang B, Estes MK, Barone C, Barniak V, O’neal CM, Ottaiano A, Madore HP, Conner ME. Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles. Vaccine. 1999;17(7–8):1005–13. doi:10.1016/S0264-410X(98)00317-X.
   PubMed Web of Science ®Google Scholar
• Jiang B, Wang Y, Glass RI. Does a monovalent inactivated human rotavirus vaccine induce heterotypic immunity? Evidence from animal studies. Hum Vaccin Immunother. 2013;9(8):1634–37. doi:10.4161/hv.24958.
   PubMed Web of Science ®Google Scholar
• Fix AD, Harro C, McNeal M, Dally L, Flores J, Robertson G, Boslego JW, Cryz S. Safety and immunogenicity of a parenterally administered rotavirus VP8 subunit vaccine in healthy adults. Vaccine. 2015;33(31):3766–72. doi:10.1016/j.vaccine.2015.05.024.
   PubMed Web of Science ®Google Scholar
• Zhang B, Yi S, Ma Y, Zhang G, Zhang Y, Xie T, Li H, Sun M. Immunogenicity of a scalable inactivated rotavirus vaccine in mice. Hum Vaccin. 2011;7(2):248–57. doi:10.4161/hv.7.2.14121.
   PubMed Web of Science ®Google Scholar
• Wu JY, Zhou Y, Zhang GM, Mu GF, Yi S, Yin N, Xie Y-P, Lin X-C, Li H-J, Sun M-S. Isolation and characterization of a new candidate human inactivated rotavirus vaccine strain from hospitalized children in Yunnan, China: 2010-2013. World J Clin Cases. 2018;6(11):426–40. doi:10.12998/wjcc.v6.i11.426.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Hu X, Chen R, Wu J, Lin X, Lu C, Yin N, Tang Y, Shi P, Song Z, et al. Impact of maternal and pre-existing antibodies on immunogenicity of inactivated rotavirus vaccines. Vaccine. 2022;40(28):3843–50. doi:10.1016/j.vaccine.2022.05.036.
   PubMedGoogle Scholar
• Berkopec A. HyperQuick algorithm for discrete hypergeometric distribution. J Discrete Algorithms. 2007;5(2):341. doi:10.1016/j.jda.2006.01.001.
   Google Scholar
• Franz M, Rodriguez H, Lopes C, Zuberi K, Montojo J, Bader GD, Morris Q. GeneMANIA update 2018. Nucleic Acids Res. 2018;46(W1):W60–4. doi:10.1093/nar/gky311.
   PubMed Web of Science ®Google Scholar
• Montojo J, Zuberi K, Rodriguez H, Bader GD, Morris Q. GeneMANIA: fast gene network construction and function prediction for cytoscape. F1000research. 2014;3:153. doi:10.12688/f1000research.4572.1.
   PubMedGoogle Scholar
• Jalilvand S, Marashi SM, Shoja Z. Rotavirus VP6 preparations as a non-replicating vaccine candidates. Vaccine. 2015;33(29):3281–87. doi:10.1016/j.vaccine.2015.05.026.
   PubMed Web of Science ®Google Scholar
• Gandhi GR, Santos VS, Denadai M, da Silva Calisto VK, de Souza Siqueira Quintans J, de Oliveira ESAM, de Souza Araújo AA, Narain N, Cuevas LE, Júnior LJQ, et al. Cytokines in the management of rotavirus infection: a systematic review of in vivo studies. Cytokine. 2017;96:152–60. doi:10.1016/j.cyto.2017.04.013.
   PubMed Web of Science ®Google Scholar
• Ye L, Jiang Y, Yang G, Yang W, Hu J, Cui Y, Shi C, Liu J, Wang C. Murine bone marrow-derived DCs activated by porcine rotavirus stimulate the Th1 subtype response in vitro. Microb Pathog. 2017;110:325–34. doi:10.1016/j.micpath.2017.07.015.
   PubMed Web of Science ®Google Scholar
• Mahmoudzadeh S, Nozad Charoudeh H, Marques CS, Bahadory S, Ahmadpour E. The role of IL-12 in stimulating NK cells against Toxoplasma gondii infection: a mini-review. Parasitol Res. 2021;120(7):2303–09. doi:10.1007/s00436-021-07204-w.
   PubMed Web of Science ®Google Scholar
• Tait Wojno ED, Hunter CA, Stumhofer JS. The immunobiology of the interleukin-12 family: room for discovery. Immunity. 2019;50(4):851–70. doi:10.1016/j.immuni.2019.03.011.
   PubMed Web of Science ®Google Scholar
• Holmgren J, Parashar UD, Plotkin S, Louis J, Ng SP, Desauziers E, Picot V, Saadatian-Elahi M. Correlates of protection for enteric vaccines. Vaccine. 2017;35(26):3355–63. doi:10.1016/j.vaccine.2017.05.005.
   PubMed Web of Science ®Google Scholar
• Desselberger U, Huppertz HI. Immune responses to rotavirus infection and vaccination and associated correlates of protection. J Infect Dis. 2011;203(2):188–95. doi:10.1093/infdis/jiq031.
   PubMed Web of Science ®Google Scholar
• Angel J, Steele AD, Franco MA. Correlates of protection for rotavirus vaccines: possible alternative trial endpoints, opportunities, and challenges. Hum Vaccin Immunother. 2014;10(12):3659–71. doi:10.4161/hv.34361.
   PubMed Web of Science ®Google Scholar
• Clarke E, Desselberger U. Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings. Mucosal Immunol. 2015;8(1):1–17. doi:10.1038/mi.2014.114.
   PubMed Web of Science ®Google Scholar
• Caddy SL, Vaysburd M, Wing M, Foss S, Andersen JT, O’connell K, Mayes K, Higginson K, Iturriza-Gómara M, Desselberger U, et al. Intracellular neutralisation of rotavirus by VP6-specific IgG. PLoS Pathog. 2020;16(8):e1008732. doi:10.1371/journal.ppat.1008732.
   PubMed Web of Science ®Google Scholar
• Campbell JS, Davidson AJ, Todd H, Rodrigues F, Elliot AM, Early JJ, Lyons DA, Feng Y, Wood W. PTPN21/Pez is a novel and evolutionarily conserved key regulator of inflammation in vivo. Curr Biol. 2021;31(4):875–83 e5. doi:10.1016/j.cub.2020.11.014.
   PubMed Web of Science ®Google Scholar
• Zhu L, Yin H, Qian T, Qi GJ, Ren JS, Wang Y, Qi B-X. Distinct expression and clinical value of aquaporin 4 in children with hand, foot and mouth disease caused by enterovirus 71. J Med Virol. 2022;94(2):587–93. doi:10.1002/jmv.25475.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Howatt DA, Gizard F, Nomiyama T, Findeisen HM, Heywood EB, Jones KL, Conneely OM, Daugherty A, Bruemmer D. Deficiency of the NR4A orphan nuclear receptor NOR1 decreases monocyte adhesion and atherosclerosis. Circ Res. 2010;107(4):501–11. doi:10.1161/CIRCRESAHA.110.222083.
   PubMed Web of Science ®Google Scholar
• Ostermann G, Weber KS, Zernecke A, Schroder A, Weber C. JAM-1 is a ligand of the β2 integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol. 2002;3(2):151–58. doi:10.1038/ni755.
   PubMed Web of Science ®Google Scholar
• Fraemohs L, Koenen RR, Ostermann G, Heinemann B, Weber C. The functional interaction of the β2 integrin lymphocyte function-associated antigen-1 with junctional adhesion molecule-A is mediated by the I domain. J Immunol. 2004;173(10):6259–64. doi:10.4049/jimmunol.173.10.6259.
   PubMed Web of Science ®Google Scholar
• Korbecki J, Barczak K, Gutowska I, Chlubek D, Baranowska-Bosiacka I. CXCL1: gene, promoter, regulation of expression, mRNA stability, regulation of activity in the intercellular space. Int J Mol Sci. 2022;23(2):792. doi:10.3390/ijms23020792.
   PubMed Web of Science ®Google Scholar
• Singh A, Bisht P, Bhattacharya S, Guchhait P. Role of platelet cytokines in dengue virus infection. Front Cell Infect Microbiol. 2020;10:561366. doi:10.3389/fcimb.2020.561366.
   PubMed Web of Science ®Google Scholar
• Karin N, Wildbaum G. The role of chemokines in adjusting the balance between CD4+ effector T cell subsets and FOXp3-negative regulatory T cells. Int Immunopharmacol. 2015;28(2):829–35. doi:10.1016/j.intimp.2015.03.037.
   PubMed Web of Science ®Google Scholar